Oligonucleotide-Peptide Complexes: Phase Control by Hybridization. 2018

Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
Institute for Molecular Engineering, University of Chicago , Chicago, Illinois 60637, United States.

When oppositely charged polymers are mixed, counterion release drives phase separation; understanding this process is a key unsolved problem in polymer science and biophysical chemistry, particularly for nucleic acids, polyanions whose biological functions are intimately related to their high charge density. In the cell, complexation by basic proteins condenses DNA into chromatin, and membraneless organelles formed by liquid-liquid phase separation of RNA and proteins perform vital functions and have been linked to disease. Electrostatic interactions are also the primary method used for assembly of nanoparticles to deliver therapeutic nucleic acids into cells. This work describes complexation experiments with oligonucleotides and cationic peptides spanning a wide range of polymer lengths, concentrations, and structures, including RNA and methylphosphonate backbones. We find that the phase of the complexes is controlled by the hybridization state of the nucleic acid, with double-stranded nucleic acids forming solid precipitates while single-stranded oligonucleotides form liquid coacervates, apparently due to their lower charge density. Adding salt "melts" precipitates into coacervates, and oligonucleotides in coacervates remain competent for sequence-specific hybridization and phase change, suggesting the possibility of environmentally responsive complexes and nanoparticles for therapeutic or sensing applications.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
January 2012, Chemistry (Weinheim an der Bergstrasse, Germany),
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
December 2005, Journal of the American Chemical Society,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
January 2021, The journal of physical chemistry. B,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
February 1993, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
January 2002, Analytical chemistry,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
December 2007, Bioorganic & medicinal chemistry letters,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
January 1987, Methods in enzymology,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
January 1997, Bioconjugate chemistry,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
August 2018, Journal of peptide science : an official publication of the European Peptide Society,
Jeffrey R Vieregg, and Michael Lueckheide, and Amanda B Marciel, and Lorraine Leon, and Alex J Bologna, and Josean Reyes Rivera, and Matthew V Tirrell
December 1987, Nucleic acids research,
Copied contents to your clipboard!